Transcenta

Developer of antibody-based therapeutics

placeSuzhou, Jiangsu, China calendar_todayFounded 2019 groups318 employees language transcenta.com

Social engagement

Social engagement: 2.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Fortune Capital, China Merchants Capital, China Equity Group, Lilly Asia Ventures.

Investor typeCountShare
Venture capital323%
Private equity538%
Other / undisclosed538%

Recent activity

13 Apr 2026
Event
AACR Annual Meeting
31 Mar 2026
Milestone
regulatory
30 Mar 2026
Leadership hire
Head of Global Partnerships for HiCB
Coming soon